Premarket Decliner
ITRM Iterum Therapeutics PLC - Ordinary Share2.29-0.02-0.9%
Premarket:1.58-0.71 (-31.0%)
Iterum Therapeutics Provides Regulatory Update
Globe NewswireThu, 1-Jul 6:30 PM
Premarket Gainer
ITRM Iterum Therapeutics PLC - Ordinary Share0.64-0.01-1.1%
Premarket:1.47+0.83 (+128.6%)
Iterum Therapeutics Announces Positive Pre-NDA Meeting with FDA for Sulopenem for Treatment of Uncomplicated Urinary Tract Infections
Globe NewswireWed, 30-Sep 7:00 AM
